Home
About
Overview
Sharing Data
ORCID
Help
History (21)
A highly bioavailable omega-3 free fatty acid formulation improves the cardiovascular risk profile in high-risk, statin-treated patients with residual hypertriglyceridemia (the ESPRIT trial).
Evaluation of lipids, drug concentration, and safety parameters following cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib in patients with or at high risk for coronary heart disease.
Bilateral Vestibulopathy
Personalized medicine: building the GPS to take us there.
Production of a-galactosylceramide by a prominent member of the human gut microbiota.
See All 21 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Production of a-galactosylceramide by a prominent member of the human gut microbiota.
Production of a-galactosylceramide by a prominent member of the human gut microbiota. PLoS Biol. 2013 Jul; 11(7):e1001610.
View in:
PubMed
subject areas
Animals
Bacteroides fragilis
Cells, Cultured
Galactosylceramides
Humans
Mice
Mutation
Natural Killer T-Cells
authors with profiles
Laurie Comstock